{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Candida", "collyrium", "eye fungal infections", "liposome", "membrane potential dissipation", "ozonated oil"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32855851", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "19"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "07", "Day": "02"}], "ELocationID": ["4", "10.1167/tvst.9.8.4"], "Journal": {"ISSN": "2164-2591", "JournalIssue": {"Volume": "9", "Issue": "8", "PubDate": {"Year": "2020", "Month": "Jul"}}, "Title": "Translational vision science & technology", "ISOAbbreviation": "Transl Vis Sci Technol"}, "ArticleTitle": "Antimycotic Activity of Ozonized Oil in Liposome Eye Drops against <i>Candida</i> spp.", "Pagination": {"StartPage": "4", "MedlinePgn": "4"}, "Abstract": {"AbstractText": ["This study aims to investigate the antifungal activity and mechanism of action of ozonized oil eye drops in liposomes (Ozodrop), commercialized as eye lubricant for the treatment of dry eye syndrome and eye inflammation. The activity was tested against four clinical <i>Candida</i> species: <i>C</i><i>albicans,</i><i>C</i><i>glabrata,</i><i>C</i><i>krusei</i>, and <i>C</i><i>orthopsilosis</i>.", "The antifungal activity of the eye drop solution was ascertained by microdilution method in accordance with EUCAST obtaining the minimum inhibitory concentration for Ozodrop. The mechanism of action was further investigated in <i>C</i><i>albicans</i> by measuring cell vitality, intracellular reactive oxygen species production, levels of cellular and mitochondrial (\u2206\u03a8<sub>m</sub>) membrane potential, and the extent of membrane lipid peroxidation.", "All <i>Candida</i> isolates were susceptible to Ozodrop with minimum inhibitory concentration values ranging from 0.195% (v/v) for <i>C</i><i>glabrata</i> to 6.25% (v/v) for <i>C</i><i>orthopsilosis</i>. After 1 hour of exposure at the minimum inhibitory concentration value about 30% of cells were killed, reaching about 70% at the highest Ozodrop value. After Ozodrop exposure, <i>C</i><i>albicans</i> showed cell membrane depolarization, increased levels of lipid peroxidation, depolarized \u2206\u03a8<sub>m</sub>, and increased reactive oxygen species generation.", "The significant increases in reactive oxygen species production cause the accumulation of reactive oxygen species-associated damages leading to progressive Candida cell dysfunction.", "The antifungal activity of Ozodrop was demonstrated at concentrations several times lower than the concentration that can be retrieved in ocular surface after its application. The antifungal activity of the eye drops Ozodrop would represent an interesting off-label indication for a product basically conceived as an eye lubricant."], "CopyrightInformation": "Copyright 2020 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Celenza", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Iorio", "ForeName": "Roberto", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Cracchiolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Petricca", "ForeName": "Sabrina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Health Sciences \"Vincenzo Tiberio\", University of Molise, Campobasso, Italy."}], "LastName": "Costagliola", "ForeName": "Ciro", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life, Health and Environmental Sciences, University of l'Aquila, L'Aquila, Italy."}], "LastName": "Cinque", "ForeName": "Benedetta", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Segatore", "ForeName": "Bernardetta", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Amicosante", "ForeName": "Gianfranco", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."}], "LastName": "Bellio", "ForeName": "Pierangelo", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Transl Vis Sci Technol", "NlmUniqueID": "101595919", "ISSNLinking": "2164-2591"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antifungal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}, {"RegistryNumber": "0", "NameOfSubstance": "Ophthalmic Solutions"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antifungal Agents"}, {"QualifierName": [], "DescriptorName": "Candida"}, {"QualifierName": [], "DescriptorName": "Liposomes"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Ophthalmic Solutions"}], "CoiStatement": "Disclosure: G. Celenza, FBVision (R); R. Iorio, FBVision (F); S. Cracchiolo, None; S. Petricca, None; C. Costagliola, None; B. Cinque, None; B. Segatore, None; G. Amicosante, None; P. Bellio, None"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011; 36: 179\u2013189, doi:10.3109/02713683.2010.533810.", "ArticleIdList": ["10.3109/02713683.2010.533810", "21158591"]}, {"Citation": "Mahmoudi S, Masoomi A, Ahmadikia K, et al. .. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses. 2018; 61: 916\u2013930, doi:10.1111/myc.12822.", "ArticleIdList": ["10.1111/myc.12822", "29992633"]}, {"Citation": "Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004; 15: 321\u2013327.", "ArticleIdList": ["15232472"]}, {"Citation": "Srinivasan M. Infective keratitis: a challenge to Indian ophthalmologists. Indian J Ophthalmol. 2007; 55: 5\u20136, doi:10.4103/0301-4738.29487.", "ArticleIdList": ["10.4103/0301-4738.29487", "17189878"]}, {"Citation": "Kredics L, Narendran V, Shobana CS, et al. .. Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses. 2015; 58: 243\u2013260, doi:10.1111/myc.12306.", "ArticleIdList": ["10.1111/myc.12306", "25728367"]}, {"Citation": "Ong HS, Fung SSM, Macleod D, Dart JKG, Tuft SJ, Burton MJ. Altered patterns of fungal keratitis at a London ophthalmic referral hospital: an eight-year retrospective observational study. Am J Ophthalmol. 2016; 168: 227\u2013236, doi:10.1016/j.ajo.2016.05.021.", "ArticleIdList": ["10.1016/j.ajo.2016.05.021", "PMC4977014", "27287820"]}, {"Citation": "Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol. 2008; 92: 466\u2013468, doi:10.1136/bjo.2007.133405.", "ArticleIdList": ["10.1136/bjo.2007.133405", "18369061"]}, {"Citation": "Lamaris GA, Esmaeli B, Chamilos G, et al. .. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008; 27: 343\u2013347, doi:10.1007/s10096-007-0443-9.", "ArticleIdList": ["10.1007/s10096-007-0443-9", "18183439"]}, {"Citation": "Smith SR, Kroll AJ, Lou PL, Ryan EA. Endogenous bacterial and fungal endophthalmitis. Int Ophthalmol Clin. 2007; 47: 173\u2013183, doi:10.1097/IIO.0b013e31803778f7.", "ArticleIdList": ["10.1097/IIO.0b013e31803778f7", "17450017"]}, {"Citation": "Ozdek S, Urgancioglu B, Ozturk S. Recurrent endogenous Candida. Ann Ophthalmol (Skokie). 2009; 41: 118\u2013120.", "ArticleIdList": ["19845230"]}, {"Citation": "Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007; 27: 662\u2013680, doi:10.1097/IAE.0b013e3180323f96.", "ArticleIdList": ["10.1097/IAE.0b013e3180323f96", "17621174"]}, {"Citation": "Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother. 2007; 51: 239\u2013244, doi:10.1128/AAC.00762-06.", "ArticleIdList": ["10.1128/AAC.00762-06", "PMC1797668", "17060517"]}, {"Citation": "O'day DM, Head WS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin b and natamycin. Curr Eye Res. 1986; 5: 877\u2013882, doi:10.3109/02713688609029240.", "ArticleIdList": ["10.3109/02713688609029240", "3490954"]}, {"Citation": "Slowik M, Biernat MM, Urbaniak-Kujda D, Kapelko-Slowik K, Misiuk-Hojlo M. Mycotic infections of the eye. Adv Clin Exp Med. 2015; 24: 1113\u20131117, doi:10.17219/acem/50572.", "ArticleIdList": ["10.17219/acem/50572", "26771986"]}, {"Citation": "Stone D, Tan JF. Fungal keratitis: update for 2014. Curr Ophthalmol Rep. 2014; 2: 129\u2013136, doi:10.1007/s40135-014-0047-3.", "ArticleIdList": ["10.1007/s40135-014-0047-3"]}, {"Citation": "Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013; 7: 209\u2013218, doi:10.1007/s12281-013-0150-1.", "ArticleIdList": ["10.1007/s12281-013-0150-1", "PMC3768010", "24040467"]}, {"Citation": "Florcruz NV, Evans JR.. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015; 4: CD004241, doi:10.1002/14651858.CD004241.pub4.", "ArticleIdList": ["10.1002/14651858.CD004241.pub4", "25855311"]}, {"Citation": "Ness T, Kern W V, Frank U, Reinhard T. Postoperative nosocomial endophthalmitis: is perioperative antibiotic prophylaxis advisable? A single centre's experience. J Hosp Infect. 2011; 78: 138\u2013142, doi:10.1016/j.jhin.2011.02.004.", "ArticleIdList": ["10.1016/j.jhin.2011.02.004", "21450368"]}, {"Citation": "Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery: III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984; 102: 728\u2013729, doi:10.1001/archopht.1984.01040030584025.", "ArticleIdList": ["10.1001/archopht.1984.01040030584025", "6721765"]}, {"Citation": "Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002; 109: 13\u201324, doi:10.1016/S0161-6420(01)00899-5.", "ArticleIdList": ["10.1016/S0161-6420(01)00899-5", "11772573"]}, {"Citation": "Barkana Y, Almer Z, Segal O, Lazarovitch Z, Avni I, Zadok D. Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand. 2005; 83: 360\u2013363, doi:10.1111/j.1600-0420.2005.00414.x.", "ArticleIdList": ["10.1111/j.1600-0420.2005.00414.x", "15948791"]}, {"Citation": "Wilson A, Khan S, Vatsia S, et al. .. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017; 7: 212\u2013219, doi:10.4103/2045-9912.215752.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Mauro R Di, Cantarella G, Bernardini R, et al. .. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019; 20: 634, doi:10.3390/ijms20030634.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}, {"Citation": "Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011; 2: 66\u201370, doi:10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Riv Ital di Ossigeno-Ozonoterapia. 2006; 5: 93\u2013104, doi:10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Travagli V, Zanardi I, Valacchi G, Bocci V. Ozone and ozonated oils in skin diseases: a review. Mediators Inflamm. 2010; 2010: 610418, doi:10.1155/2010/610418.", "ArticleIdList": ["10.1155/2010/610418", "PMC2910505", "20671923"]}, {"Citation": "Zeng J, Lu J.. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol. 2018; 56: 235\u2013241, doi:10.1016/j.intimp.2018.01.040.", "ArticleIdList": ["10.1016/j.intimp.2018.01.040", "29414657"]}, {"Citation": "Pietrocola G, Ceci M, Preda F, Poggio C, Colombo M. Evaluation of the antibacterial activity of a new ozonized olive oil against oral and periodontal pathogens. J Clin Exp Dent. 2018; 10: e1103\u2013e1108, doi:10.4317/jced.54929.", "ArticleIdList": ["10.4317/jced.54929", "PMC6311406", "30607228"]}, {"Citation": "Gupta G, Mansi B.. Ozone therapy in periodontics. J Med Life. 2012; 5: 59\u201367.", "ArticleIdList": ["PMC3307081", "22574088"]}, {"Citation": "Bhatia A, Munk P, Lee D, Elias G, Murphy K. Percutaneous ozone treatment for herniated lumbar discs: 1-year follow-up of a multicenter pilot study of a handheld disposable ozone-generating device. J Vasc Interv Radiol. 2019; 30: 752\u2013760, doi:10.1016/j.jvir.2018.09.037.", "ArticleIdList": ["10.1016/j.jvir.2018.09.037", "30922796"]}, {"Citation": "Seyam O, Smith NL, Reid I, Gandhi J, Jiang W, Khan SA. Clinical utility of ozone therapy for musculoskeletal disorders. Med Gas Res. 2018; 8: 103\u2013110, doi:10.4103/2045-9912.241075.", "ArticleIdList": ["10.4103/2045-9912.241075", "PMC6178642", "30319765"]}, {"Citation": "Izadi M, Kheirjou R, Mohammadpour R, et al. .. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes Metab Syndr Clin Res Rev. 2019; 13: 822\u2013825, doi:10.1016/j.dsx.2018.11.060.", "ArticleIdList": ["10.1016/j.dsx.2018.11.060", "30641815"]}, {"Citation": "Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based eye drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol. 2018; 9: 287\u2013298, doi:10.1159/000488846.", "ArticleIdList": ["10.1159/000488846", "PMC6006625", "29928225"]}, {"Citation": "Moureu S, Violleau F, Ali Haimoud-Lekhal D, Calmon A. Ozonation of sunflower oils: impact of experimental conditions on the composition and the antibacterial activity of ozonized oils. Chem Phys Lipids. 2015; 186: 79\u201385, doi:10.1016/j.chemphyslip.2015.01.004.", "ArticleIdList": ["10.1016/j.chemphyslip.2015.01.004", "25623845"]}, {"Citation": "Iorio R, Castellucci A, Rossi G, et al. .. Mancozeb affects mitochondrial activity, redox status and ATP production in mouse granulosa cells. Toxicol Vitr. 2015; 30: 438\u2013445, doi:10.1016/j.tiv.2015.09.018.", "ArticleIdList": ["10.1016/j.tiv.2015.09.018", "26407525"]}, {"Citation": "Petricca S, Flati V, Celenza G, et al. .. Tebuconazole and econazole act synergistically in mediating mitochondrial stress, energy imbalance, and sequential activation of autophagy and apoptosis in mouse Sertoli TM4 cells: possible role of AMPK/ULK1 axis. Toxicol Sci. 2019; 169: 209\u2013223, doi:10.1093/toxsci/kfz031.", "ArticleIdList": ["10.1093/toxsci/kfz031", "30698772"]}, {"Citation": "Azarpazhooh A, Limeback H.. The application of ozone in dentistry: a systematic review of literature. J Dent. 2008; 36: 104\u2013116, doi:10.1016/j.jdent.2007.11.008.", "ArticleIdList": ["10.1016/j.jdent.2007.11.008", "18166260"]}, {"Citation": "Sega A, Zanardi I, Chiasserini L, Gabbrielli A, Bocci V, Travagli V. Properties of sesame oil by detailed 1H and 13C NMR assignments before and after ozonation and their correlation with iodine value, peroxide value, and viscosity measurements. Chem Phys Lipids. 2010; 163: 148\u2013156, doi:10.1016/j.chemphyslip.2009.10.010.", "ArticleIdList": ["10.1016/j.chemphyslip.2009.10.010", "19900426"]}, {"Citation": "Men\u00e9ndez S, Falc\u00f3n L, Maqueira Y. Therapeutic efficacy of topical OLEOZON \u00ae in patients suffering from onychomycosis. Mycoses. 2011; 54: e272\u2013e277, doi:10.1111/j.1439-0507.2010.01898.x.", "ArticleIdList": ["10.1111/j.1439-0507.2010.01898.x", "20492527"]}, {"Citation": "Guerrer L V, Cunha KC, Nogueira MCL, Cardoso CC, Soares MMCN, Almeida MTG. In vitro antifungal activity of ozonized sunflower oil on yeasts from onychomycosis. Braz J Microbiol. 2012; 43: 1315\u20131318, doi:10.1590/S1517-838220120004000011.", "ArticleIdList": ["10.1590/S1517-838220120004000011", "PMC3769014", "24031958"]}, {"Citation": "Pai SA, Gagangras SA, Kulkarni SS, Majumdar AS. Potential of ozonated sesame oil to augment wound healing in rats. Indian J Pharm Sci. 2014; 76: 87\u201392.", "ArticleIdList": ["PMC4007261", "24799744"]}, {"Citation": "Ouf SA, Moussa TA, Abd-Elmegeed AM, Eltahlawy SR. Anti-fungal potential of ozone against some dermatophytes. Brazilian J Microbiol. 2016; 47: 697\u2013702, doi:10.1016/j.bjm.2016.04.014.", "ArticleIdList": ["10.1016/j.bjm.2016.04.014", "PMC4927674", "27287337"]}, {"Citation": "Sechi LA, Lezcano I, Nunez N, et al. .. Antibacterial activity of ozonized sunflower oil (Oleozon). J Appl Microbiol. 2001; 90: 279\u2013284, doi:10.1046/j.1365-2672.2001.01235.x.", "ArticleIdList": ["10.1046/j.1365-2672.2001.01235.x", "11168731"]}, {"Citation": "Kashiwagi K, Saito K, Wang YD, Takahashi H, Ishijima K, Tsukahara S. Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica. 2001; 215: 351\u2013356, doi:10.1159/000050884.", "ArticleIdList": ["10.1159/000050884", "11528260"]}, {"Citation": "Georgopapadakou NH, Dix BA, Smith SA, Freudenberger J, Funke PT. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans. Antimicrob Agents Chemother. 1987; 31: 46\u201351, doi:10.1128/AAC.31.1.46.", "ArticleIdList": ["10.1128/AAC.31.1.46", "PMC174649", "3551826"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "3", "Day": "31"}, {"Year": "2020", "Month": "5", "Day": "12"}, {"Year": "2020", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "7", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["32855851", "PMC7422790", "10.1167/tvst.9.8.4", "TVST-20-2469"]}}], "PubmedBookArticle": []}